Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

The Identification of Alpha-Synuclein as the First Parkinson Disease Gene.

Nussbaum RL.

J Parkinsons Dis. 2017;7(s1):S45-S51. doi: 10.3233/JPD-179003.

2.

Cancer in Parkinson's disease.

Tacik P, Curry S, Fujioka S, Strongosky A, Uitti RJ, van Gerpen JA, Diehl NN, Heckman MG, Wszolek ZK.

Parkinsonism Relat Disord. 2016 Oct;31:28-33. doi: 10.1016/j.parkreldis.2016.06.014. Epub 2016 Jun 20.

PMID:
27372241
3.

Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic.

West AB.

Mov Disord. 2015 Feb;30(2):180-9. doi: 10.1002/mds.26075. Epub 2014 Dec 1. Review.

4.

Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.

Wray S, Self M; NINDS Parkinson's Disease iPSC Consortium; NINDS Huntington's Disease iPSC Consortium; NINDS ALS iPSC Consortium, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, Marti-Masso JF, Preza E, Barker S, Sutherland M, Corriveau RA, D'Andrea M, Schapira AH, Uitti RJ, Guttman M, Opala G, Jasinska-Myga B, Puschmann A, Nilsson C, Espay AJ, Slawek J, Gutmann L, Boeve BF, Boylan K, Stoessl AJ, Ross OA, Maragakis NJ, Van Gerpen J, Gerstenhaber M, Gwinn K, Dawson TM, Isacson O, Marder KS, Clark LN, Przedborski SE, Finkbeiner S, Rothstein JD, Wszolek ZK, Rossor MN, Hardy J.

PLoS One. 2012;7(8):e43099. doi: 10.1371/journal.pone.0043099. Epub 2012 Aug 27.

5.

Leucine-rich repeat kinase 2 for beginners: six key questions.

Kett LR, Dauer WT.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a009407. doi: 10.1101/cshperspect.a009407. Review.

6.

Genetically engineered mouse models of Parkinson's disease.

Crabtree DM, Zhang J.

Brain Res Bull. 2012 May 1;88(1):13-32. doi: 10.1016/j.brainresbull.2011.07.019. Epub 2011 Aug 3. Review.

7.

Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy?

Plowey ED, Chu CT.

Neurobiol Dis. 2011 Jul;43(1):60-7. doi: 10.1016/j.nbd.2010.10.011. Epub 2010 Oct 20. Review.

8.

Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation.

Wider C, Dickson DW, Wszolek ZK.

Neurodegener Dis. 2010;7(1-3):175-9. doi: 10.1159/000289232. Epub 2010 Mar 3.

9.

Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.

Hasegawa K, Stoessl AJ, Yokoyama T, Kowa H, Wszolek ZK, Yagishita S.

Parkinsonism Relat Disord. 2009 May;15(4):300-6. doi: 10.1016/j.parkreldis.2008.07.010. Epub 2008 Sep 18.

10.

Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.

Simón-Sánchez J, Singleton AB.

Hum Mol Genet. 2008 Jul 1;17(13):1988-93. doi: 10.1093/hmg/ddn096. Epub 2008 Mar 25.

11.

The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Zimprich A, Müller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z, Gasser T.

Am J Hum Genet. 2004 Jan;74(1):11-9. Epub 2003 Dec 19. Erratum in: Am J Hum Genet. 2004 Sep;75(3):534.

12.

Genes and parkinsonism.

Wood N.

J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):305-9. No abstract available.

Supplemental Content

Support Center